The European Commission plans to tighten the surveillance of medical devices after a scandal involving faulty breast implants.
This will be done within the existing legal framework at first; measures could include more surprise inspections and additional testing of marketed products. In addition, the Commission is carrying out a “stress test” of the EU legislation before revising it.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.